Most literature describing stent-related major adverse cardiovascular events (MACE) following percutaneous coronary intervention (PCI) consider only the first year post-intervention. Very little is known about the frequency and predictors of very-late stent-related events (>1 year and ≤5 years post-intervention), or MACE by stent type. This large-scale, individual patient data … [Read more...] about Very late stent-related events may occur in 50% of patients
Feature
Top 10 highlights of ESC Congress 2020
This year’s European Society of Cardiology (ESC) congress was the first ever to be held entirely digitally, due to the COVID-19 pandemic. Approximately 116,000 healthcare providers from 211 countries participated, and there were many illuminating presentations shared to help guide the management of cardiovascular disease. Here are our top 10 highlights listed by … [Read more...] about Top 10 highlights of ESC Congress 2020
EXCEL trial: Repeat revascularization after CABG and PCI for left main disease
Repeat revascularization occurs more often following percutaneous coronary intervention (PCI) than coronary artery bypass grafting (CABG). The need for repeat revascularization is a less important clinical endpoint than death, stroke or myocardial infarction. However, it can have an impact on quality of life, risk of hospitalization and mortality. In the present study of … [Read more...] about EXCEL trial: Repeat revascularization after CABG and PCI for left main disease
Clinical impact of FFR in jailed LCX after left main simple crossover stenting
Stenting of coronary artery bifurcation lesions can be challenging, especially given the potential compromise of blood flow into the “jailed” side branch. After stenting, optimal results are obtained by assessing fractional flow reserve (FFR) in the side branch. Such functional assessment is considered more reliable than angiographically determined stenosis, which tends to … [Read more...] about Clinical impact of FFR in jailed LCX after left main simple crossover stenting
iMODERN: When to treat non-culprit lesions in STEMI
The iMODERN trial (“iFR Guided Multi-vessel Revascularization During Percutaneous Coronary Intervention for Acute Myocardial Infarction.”) trial is an ongoing multinational study. This study will provide important knowledge on the best practice for the assessment and treatment of multi-vessel disease involving ST-segment elevation myocardial infarction (STEMI) patients. We … [Read more...] about iMODERN: When to treat non-culprit lesions in STEMI